Gastroenterology
Volume 138, Issue 1 , Pages 34-36, January 2010

Do Differences in Pegylation of Interferon Alfa Matter?

  • Stefan Zeuzem

      Affiliations

    • Corresponding Author InformationReprint requests Address requests for reprints to: Stefan Zeuzem, MD, Department of Medicine 1, J.W. Goethe University Hospital, Theodor-Stern-Kai 7, 60590 Frankfurt A.M., Germany

Department of Medicine, J.W. Goethe University Hospital, Frankfurt, Germany

published online 23 November 2009.

No abstract is available. To read the body of this article, please view the Full Text online.

 

 Conflicts of interest The author discloses the following: Clinical investigator, consultant and member of speaker's bureau for Human Genome Sciences, Novartis, Roche, and Schering-Plough.

PII: S0016-5085(09)02051-4

doi:10.1053/j.gastro.2009.11.034

Refers to article:

  • Editorial Accompanies Article Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C , 22 September 2009

    Maria Grazia Rumi, Alessio Aghemo, Gian Maria Prati, Roberta D'Ambrosio, Maria Francesca Donato, Roberta Soffredini, Ersilio Del Ninno, Antonio Russo, Massimo Colombo
    Gastroenterology January 2010 (Vol. 138, Issue 1, Pages 108-115)

  • Additional Online Content AvailableEditorial Accompanies Article Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection , 22 October 2009

    Antonio Ascione, Massimo De Luca, Maria Teresa Tartaglione, Filippo Lampasi, Giovan Giuseppe Di Costanzo, Alfonso Galeota Lanza, Francesco Paolo Picciotto, Giuseppina Marino–Marsilia, Luca Fontanella, Gioacchino Leandro
    Gastroenterology January 2010 (Vol. 138, Issue 1, Pages 116-122)

Gastroenterology
Volume 138, Issue 1 , Pages 34-36, January 2010

Article Tools